Rainmaker Q&A: Sterne Kessler's Eric Steffe

Law360, New York (August 16, 2013, 11:15 AM EDT) -- Eric K. Steffe is a director in Sterne Kessler Goldstein & Fox PLLC's biotechnology/chemical group in the firm's Washington, D.C., office, where he counsels clients in various fields of patent law, with special emphasis on therapeutic antibodies, vaccines, diagnostics, antisense technologies, personalized medicine and cell culturing/bioprocessing methods.

Steffe has extensive expertise in patent re-examinations, managing complicated multifamily patent portfolios protecting pipeline and FDA-approved biotech products, preserving freedom to operate, interferences and the IP issues arising out of industry collaborations and ongoing research. Provides strategic advice to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.